Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer
Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day[-1]) and followed by or...
Saved in:
Published in | British journal of cancer Vol. 76; no. 7; pp. 939 - 942 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.01.1997
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day[-1]) and followed by oral treatment (1.6 g day[-1]) for 12 months. Skeletal pain relief was only about 10% better in the clodronate than in the placebo group. The results do not support the superiority of combined intravenous and oral treatment with clodronate compared with oral administration only. |
---|---|
AbstractList | Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day[-1]) and followed by oral treatment (1.6 g day[-1]) for 12 months. Skeletal pain relief was only about 10% better in the clodronate than in the placebo group. The results do not support the superiority of combined intravenous and oral treatment with clodronate compared with oral administration only. Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day super(-1)) and followed by oral treatment (1.6 g day super(-1)) for 12 months. Skeletal pain relief was only about 10% better in the clodronate than in the placebo group. The results do not support the superiority of combined intravenous and oral treatment with clodronate compared with oral administration only. |
Author | TAUBE, T RISTELI, L RISTELI, J KYLMÄLÄ, T ELOMAA, I TAMMELA, T. L. J |
AuthorAffiliation | Department of Surgery, Tampere University Hospital, Finland |
AuthorAffiliation_xml | – name: Department of Surgery, Tampere University Hospital, Finland |
Author_xml | – sequence: 1 givenname: T surname: KYLMÄLÄ fullname: KYLMÄLÄ, T organization: Division of Urology, Department of Surgery, Tampere University Hospital, Finland – sequence: 2 givenname: T surname: TAUBE fullname: TAUBE, T organization: Department of Oncology, University of Helsinki, Finland – sequence: 3 givenname: T. L. J surname: TAMMELA fullname: TAMMELA, T. L. J organization: Division of Urology, Department of Surgery, Tampere University Hospital, Finland – sequence: 4 givenname: L surname: RISTELI fullname: RISTELI, L organization: Departments of Medical Biochemistry and Clinical Chemistry, University of Oulu, Finland – sequence: 5 givenname: J surname: RISTELI fullname: RISTELI, J organization: Departments of Medical Biochemistry and Clinical Chemistry, University of Oulu, Finland – sequence: 6 givenname: I surname: ELOMAA fullname: ELOMAA, I organization: Department of Oncology, University of Helsinki, Finland |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2812331$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9328156$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUuLFDEUhYOMjD2jO7dCFuLKKvOoR7IRpPEFA250HVKpGztDOimT1Mj8BX-1KbppdFWkzpdz7s25QVchBkDoJSUtJVy8m-5NS6Uc206IJ2hHe84aKth4hXaEkLEhkpFn6Cbn-3qURIzX6FpyJmg_7NCffQwmHl3RoWDXPrRYhxnHpD02Ps4pBl0Au4DLAXAC78DiaPFUR8CLrv8brPEc18lDM3lX7y5eG5hiY2IoKXoPM85lnR83k0UXB6Fk_NuVA15SzGWzNzoYSM_RU6t9hhfn7y368enj9_2X5u7b56_7D3eN6YauNHIQMzDNhbb9CIMFUjfh1pgRDBBttJEdcEmBAaHGUjn0IKzsSM97MUvDb9H7k--yTkeYTR2orquW5I46PaqonfpfCe6gfsYHxRgTZBiqwZuzQYq_VshFHV024L0OENes6MD7cehoBd-eQFM3zQnsJYQStXWnandq607V7ir-6t_BLvC5rKq_Pus6G-1tqs_m8gWrEON8S8UnrFa3JrjoNWuL2pL-AvKJses |
CODEN | BJCAAI |
CitedBy_id | crossref_primary_10_1016_S0305_7372_03_00071_9 crossref_primary_10_1016_j_clon_2004_07_009 crossref_primary_10_1097_00042307_200209000_00008 crossref_primary_10_1007_s11916_000_0078_3 crossref_primary_10_1016_j_eursup_2004_08_009 crossref_primary_10_1097_00042307_200405000_00008 crossref_primary_10_1111_pme_12016 crossref_primary_10_1002_14651858_CD005247_pub2 crossref_primary_10_1016_j_eursup_2004_08_010 crossref_primary_10_1038_sj_pcan_4500607 crossref_primary_10_1097_00045391_200401000_00012 crossref_primary_10_3816_CGC_2002_n_016 crossref_primary_10_1016_S0022_5347_05_65498_5 crossref_primary_10_1586_ecp_12_21 crossref_primary_10_1634_theoncologist_2008_0209 crossref_primary_10_1179_joc_2005_17_5_555 crossref_primary_10_1097_00001622_199905000_00016 crossref_primary_10_1111_iju_13170 crossref_primary_10_1177_0269216316639793 crossref_primary_10_1517_14712598_6_12_1333 crossref_primary_10_1517_14728214_8_2_469 crossref_primary_10_1200_JCO_2003_05_147 crossref_primary_10_4137_CMT_S1958 crossref_primary_10_1016_j_bone_2020_115715 crossref_primary_10_1097_00000421_200212001_00003 crossref_primary_10_1002_14651858_CD006250_pub2 crossref_primary_10_1016_j_ejca_2012_07_016 crossref_primary_10_3390_ijms17091415 crossref_primary_10_1016_j_eururo_2006_05_017 crossref_primary_10_1016_S0002_9343_02_01101_4 crossref_primary_10_1046_j_1464_410X_2003_04494_x crossref_primary_10_1007_s10585_009_9247_x crossref_primary_10_1177_030089160308900301 crossref_primary_10_1002_14651858_CD006250 crossref_primary_10_1007_s00345_004_0472_2 crossref_primary_10_1016_S0305_7372_03_00013_6 crossref_primary_10_1200_JCO_1999_17_7_1969 crossref_primary_10_1191_026921601671919596 crossref_primary_10_1097_00005392_200112000_00004 crossref_primary_10_1634_theoncologist_9_90004_14 crossref_primary_10_3904_kjm_2017_92_2_124 crossref_primary_10_1038_sj_pcan_4500705 crossref_primary_10_1093_jnci_94_19_1458 crossref_primary_10_1517_14656566_9_16_2829 crossref_primary_10_1016_j_ctrv_2019_05_003 crossref_primary_10_1081_CNV_120014886 crossref_primary_10_1002_14651858_CD013020_pub2 crossref_primary_10_1002_14651858_CD002068 crossref_primary_10_1016_j_ucl_2004_01_001 crossref_primary_10_1111_j_1442_2042_2010_02468_x crossref_primary_10_1191_026921600701536372 crossref_primary_10_1007_s11912_006_0023_7 crossref_primary_10_3816_SCT_2006_n_012 crossref_primary_10_1002_cncr_20056 crossref_primary_10_1016_j_hoc_2006_03_011 crossref_primary_10_1016_j_ctrv_2004_03_005 crossref_primary_10_3816_CGC_2005_n_009 crossref_primary_10_2165_00024669_200302060_00004 crossref_primary_10_1188_09_CJON_701_710 crossref_primary_10_1053_j_seminoncol_2010_10_002 crossref_primary_10_1007_s00120_019_0881_x |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS |
Copyright_xml | – notice: 1997 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 5PM |
DOI | 10.1038/bjc.1997.488 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Calcium & Calcified Tissue Abstracts |
DatabaseTitleList | Calcium & Calcified Tissue Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-1827 |
EndPage | 942 |
ExternalDocumentID | 10_1038_bjc_1997_488 9328156 2812331 bjc1997488 |
Genre | Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - -Q- 02 08R 0R 23N 39C 3V. 4.4 53G 55 5GY 5RE 70F 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 8WZ A6W AADWK AAPBV AAWBL AAWTL AAYJO AAZLF ABAWZ ABDBF ABDEU ABFLS ABGIJ ABOCM ABPTK ABUWG ACGFS ACKTT ACPRK ADACO ADBBV ADBIT ADHDB ADQMX AEDAW AEJRE AENEX AEXYK AFKRA AFRAH AFSHS AGEZK AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AN0 ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBAFP BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI CAG COF CS3 DIK DU5 E3Z EAD EAP EAS EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EPL ESX EX3 F5P FDQFY FEDTE FERAY FIZPM FRJ FSGXE FYUFA GJ GX1 HCIFZ HVGLF HYE HZ IH2 J5H JSO KQ8 M1P M41 M7P NAO NAPCQ O9- OK1 P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q- Q2X RIG RNT RNTTT RPM SNX SNYQT SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UDS VH1 W2D WH7 WOW X7M XFK Y6R ZA5 ZGI --- .55 .GJ 0R~ 36B 406 6J9 AANZL AATNV AAUGY AAYFA ABLJU ACBMV ACBRV ACBYP ACGFO ACIGE ACRQY ACTTH ACVWB ADFRT ADMDM ADYYL AEFTE AEVLU AFNRJ AGAYW AGGBP AGHAI AI. AILAN AJCLW AJDOV AMRJV AMYLF AOIJS CCPQU DNIVK DPUIP EMOBN HZ~ IQODW IWAJR JZLTJ NQJWS NYICJ SOHCF SRMVM UKHRP ~02 ~8M AACDK AASML ABAKF ABZZP ACAOD ACZOJ AEFQL AEMSY AFBBN AGQEE AIGIU CGR CUY CVF ECM EIF FIGPU HMCUK NPM AAYXX CITATION 7QP 5PM |
ID | FETCH-LOGICAL-c464t-968de2a38af57e6fe08153fcc7ece0acac94e391e2e01cf1965e8f9405358d9c3 |
IEDL.DBID | RPM |
ISSN | 0007-0920 |
IngestDate | Tue Sep 17 21:24:33 EDT 2024 Thu Aug 15 23:21:58 EDT 2024 Fri Aug 23 02:27:04 EDT 2024 Sat Sep 28 08:35:43 EDT 2024 Sun Oct 29 17:08:48 EDT 2023 Thu Oct 07 19:38:39 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Human Urinary system disease Intravenous administration Prostate disease Diseases of the osteoarticular system Oral administration Malignant tumor Chemotherapy Randomization Analgesic Pain Treatment Double blind study Advanced stage Bone Male genital diseases Prostate |
Language | English |
License | CC BY 4.0 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c464t-968de2a38af57e6fe08153fcc7ece0acac94e391e2e01cf1965e8f9405358d9c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228066/ |
PMID | 9328156 |
PQID | 16357641 |
PQPubID | 23462 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2228066 proquest_miscellaneous_16357641 crossref_primary_10_1038_bjc_1997_488 pubmed_primary_9328156 pascalfrancis_primary_2812331 nature_primary_bjc1997488 |
ProviderPackageCode | ABDEU AEDAW AAZLF -Q- AADWK AAYJO 70F ADQMX EE. RNTTT SWTZT ABGIJ RNT NAO |
PublicationCentury | 1900 |
PublicationDate | 1997-01-01 |
PublicationDateYYYYMMDD | 1997-01-01 |
PublicationDate_xml | – month: 01 year: 1997 text: 1997-01-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England |
PublicationTitle | British journal of cancer |
PublicationTitleAlternate | Br J Cancer |
PublicationYear | 1997 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
SSID | ssj0009087 |
Score | 1.881078 |
Snippet | Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis nature |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 939 |
SubjectTerms | Administration, Oral Aged Aged, 80 and over Analgesics Analgesics, Non-Narcotic - administration & dosage Analgesics, Non-Narcotic - adverse effects Analgesics, Non-Narcotic - therapeutic use Biological and medical sciences Bone Neoplasms - metabolism Bone Neoplasms - secondary Clodronic Acid - administration & dosage Clodronic Acid - adverse effects Clodronic Acid - therapeutic use Collagen - metabolism Double-Blind Method Humans Injections, Intravenous Male Medical sciences Middle Aged Neuropharmacology Pain - drug therapy Pain - metabolism Peptide Fragments - blood Pharmacology. Drug treatments Procollagen - blood Prospective Studies Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology |
Title | Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer |
URI | http://dx.doi.org/10.1038/bjc.1997.488 https://www.ncbi.nlm.nih.gov/pubmed/9328156 https://search.proquest.com/docview/16357641 https://pubmed.ncbi.nlm.nih.gov/PMC2228066 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZ50BIoIX2EunlUh_Yor23Jr2OydAmFDT00kJuR5RF12chmH_0P_ded8Yts6annkYTwN2Y-jWY-MfYpqnISQYkEabELFdlYlGFohE2VUaFBv7bUjby8T-4e1NfH-PGAxWMvTFe0b8rad6sn39U_utrK9snMxjqx2bflnLIWGCpnh-wwlXI8oo9Ku0HWC2VSDi6PgqHaPZDZrPxpqDsv9dFrT9gLpC6klbIXkSY9zVet3uBXsv3zFv_in3-XUT6LS4szdjoQSn7Tb_w1OwD3hr1cDlfmb9nveePQq2p6LZjX_i-fa1dx6svnZtVUa8qeA68dRybI14CU1PLG8rJxwFtdOyE0r5pduQJRIiWteFfFVTZiKHJfQcU7jVpaY1Bp3XBK7_KWOkpodUOutX7HHhZfvs_vxPD-gjAqUVuRJ1kFkZaZtnEKiQWkD7G0xqRgINBGm1yBzEOIIAiNJW1CyGyuSDImq3Ijz9mRw92-ZzzXJlHWxDmkCZ5YY026RyaDrJISA6X22OcRg6LtZTaK7npcZgWiVhBqBaLmMa8HaBqFVjJ2tqs9zKYhiHIkZeixjyOGBf5DdDGiHTS7TRGSKF-icMR5j-g0dXARj6V7UE92Eufet6DPdiLdg49--O-ZF-ykl8qldM8lO9qud3CFBGhbXrPjm8Xt7f115_h_AE0OCS0 |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9QwEMdHpQhaCfFsRYBSH-DobBI7ryNaUS3QrTi0qLfIcWwR2DqrfXDgG_CtmclLbMUFzuNYSfy3PB7P_AzwJqpygqBEnFjsXEY25mUYam5TqWWoUdeWqpHnF8nsSn68jq_3IB5qYdqkfV3Wvlvc-K7-2uZWLm_0ZMgTm3yeTylqgUvl5A7cxfkapcMmfWDtBlmHyqQoXB4Ffb57ILJJ-U1TfV7qo24P4R46L0RL2VmTRqLmg6Va43-y3QUXf_NAbydS_rEynT2CL8M3dQkp3_3tpvT1z1u4x3_-6MfwsPdV2bvO_AT2jHsK9-f9afwz-DVtHAq2pouIWe3_8JlyFaOSf6YXTbWiwLxhtWPoZLKVQW_XssaysnGGLVXtOFesarblwvASvd2KtQliZcP7_PmFqViLv6U-egDsmlHkmC2pWIV616Ta1RFcnb2_nM54f7UD1zKRG54nWWUiJTJl49Qk1qBnEgurdWq0CZRWOpdG5KGJTBBqS9hDk9lcEo0mq3ItjmHf4ds-B5YrnUir49ykCW6GY0VIJZ2ZrBIC12DlwdthcItlR_Ao2pN3kRUoh4LkUKAcPPC6kR9boZWMre1kRwxjE5RPJETowekgjgKnJ525KGea7boIifeXSGxx3EllfLTXngfpjoZGO3G_dy2ojJb_3SvhxX8_eQoHs8v5eXH-4eLTSzjsiLwUVXoF-5vV1pygn7UpX7ez6jdRWSmj |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Jb9UwEMctKKKqhNirBij1AY7OZmc7ogdPZXlVD1SquESOFxF4daK39MA34Fszk019Faeex7bi-G95PB7_TMi7WBcIQYkZstiZiG3CqihSzGZCiUiBri3eRl6cpacX4stlcnnjqa8uaV9Vte-WV76rf3a5le2VCsY8seB8McOoBSyVQattcJ88gDkbF-NGfeTthnmPy8RIXBGHQ857yPOg-qXwjl7mg3YPyENwYJCYsrMuTVTNR61cw7-y_SMX__NCbydT3lid5k_Ij7FffVLKb3-7qXz15xby8U4df0oeDz4r_dAXeUbuGfec7C-GU_kX5O-scSDcGh8kprV_7VPpNMWr_1QtG73CAL2htaPgbNKVAa_X0sbSqnGGtrJ2jEmqm221NKwCr1fTLlGsatiQR780mnYYXGxjAMGuKUaQaYuXVrB1hepdvSQX80_fZ6dseOKBKZGKDSvSXJtY8lzaJDOpNeChJNwqlRllQqmkKoThRWRiE0bKIv7Q5LYQSKXJdaH4Idlz8LVHhBZSpcKqpDBZCpviRCJaSeUm15zDWiw98n4c4LLtSR5ldwLP8xIkUaIkSpCER7x-9KdSYEVjZzveEcRUBCQUcx555GQUSAnTFM9epDPNdl1GyP1LBZQ47OUyVR3055FsR0eTHfnfuxZQR8cBH9Tw6s41T8j--cd5-e3z2dfX5KAH82Jw6Q3Z26y25hjcrU31tptY_wCClywj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concomitant+i.v.+and+oral+clodronate+in+the+relief+of+bone+pain+%3A+a+double-blind+placebo-controlled+study+in+patients+with+prostate+cancer&rft.jtitle=British+journal+of+cancer&rft.au=KYLM%C3%84L%C3%84%2C+T&rft.au=TAUBE%2C+T&rft.au=TAMMELA%2C+T.+L.+J&rft.au=RISTELI%2C+L&rft.date=1997-01-01&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=76&rft.issue=7&rft.spage=939&rft.epage=942&rft_id=info:doi/10.1038%2Fbjc.1997.488&rft.externalDBID=n%2Fa&rft.externalDocID=2812331 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |